U.S. Banks Stock News

Earlier this week, CRA International reported that Chairman Paul A. Maleh filed a Form 144 on December 3, 2025, to sell 7,500 restricted shares under a prearranged 10b5-1 trading plan. At the same time, CRA International’s earnings outlook has been revised higher and the firm is outperforming the broader Business Services sector, highlighting growing investor attention to its consulting franchise. We’ll now examine how the stronger earnings outlook and sector outperformance influence CRA...

In the past quarter, Qiagen reported third-quarter 2025 adjusted earnings of US$0.61 per share, up 7% year over year, with revenue rising 6% and both metrics surpassing analyst estimates, while reiterating guidance for 2025 net sales growth of 4–5% and adjusted EPS of about US$2.38 at constant exchange rates. Beyond the headline beat, the combination of higher earnings, solid revenue growth and maintained full-year guidance suggests resilient demand across Qiagen’s key diagnostics and life...

Earlier in December, Alumis Inc director Srinivas Akkaraju bought roughly US$2,000,000 of common stock across three transactions, increasing his indirect holdings via Samsara Opportunity Fund and Samsara BioCapital, L.P. This cluster of insider purchases adds a fresh data point for investors watching how management’s own capital aligns with Alumis’s long-term outlook. With insider buying by a key director in focus, we’ll explore how this activity shapes Alumis’s investment narrative for...

Instacart announced a partnership in early December 2025 with The Home Depot Canada to provide same-day delivery in as fast as an hour from over 175 stores nationwide, including heavy items up to 60 pounds, with in-store pricing via the Instacart app. This collaboration makes The Home Depot Canada the first home improvement retailer with nationwide coverage on Instacart in the country, expanding its reach just as customers prepared for holiday gatherings, seasonal projects, and year-end...

EVgo (EVGO) has quietly stayed on investors’ radar as shares slipped about 10% over the past month and roughly 46% in the past year, despite solid double digit annual revenue and net income growth. See our latest analysis for EVgo. At around $3.41, EVgo’s 7 day share price return of 5.25% offers a brief bounce against a year to date share price return of negative 18.62% and a 1 year total shareholder return of negative 46.47%. This suggests fading momentum as investors reassess the pace and...

Asana (ASAN) just put fresh numbers and guidance on the table, and that combination is what has investors leaning in. The latest quarter shows steady sales growth, even as losses remain part of the story. See our latest analysis for Asana. The upbeat reaction to Asana’s earnings and guidance comes after a choppy stretch, with the latest 7 day share price return of 10.1% contrasting with a 1 year total shareholder return of around negative 36%. This suggests momentum is only just starting to...

The FDA’s green light for Axogen (AXGN) AVANCE biologics license is a genuine milestone, shifting the flagship nerve graft into a full biologic framework and sharpening the stock’s long term risk reward profile. See our latest analysis for Axogen. The FDA decision has arrived on the back of powerful momentum, with Axogen’s share price up sharply in recent months and a triple digit year to date share price return contributing to an even stronger multi year total shareholder return. This...

Blackstone, the alternative asset giant, grabbed attention after buying San Francisco's Four Seasons Hotel and rolling out a new retirement savings unit, a one-two move that pushed the stock up about 3%. See our latest analysis for Blackstone. Those moves land in the middle of a tricky year for Blackstone, with the latest $152.15 share price sitting against a negative year to date share price return but still backed by a powerful three year total shareholder return above 100 percent. This...

Genius Sports (GENI) just laid out an ambitious 2028 roadmap, pairing long term revenue and cash flow targets with a push to become core infrastructure for data driven sports media, betting and advertising. See our latest analysis for Genius Sports. The latest roadmap lands after a busy stretch, with Genius Sports striking new partnerships with FanDuel, Publicis Sports and Brazil’s CBF. Despite a softer recent patch, the stock’s year to date share price return of 27.41% and three year total...

Pebblebrook Hotel Trust (PEB) has had a choppy run lately, with the stock down over the past year but edging higher in the past month. This has prompted investors to reassess its recovery story. See our latest analysis for Pebblebrook Hotel Trust. With the share price now at $10.78, Pebblebrook’s recent 1 month share price return of 4.76% contrasts with a weak year to date share price return of 18.76%. This suggests momentum is only cautiously rebuilding after a deeper reset in total...

Recently, investors highlighted that Kirby Corporation’s inland marine transportation business has come under pressure as softened barge utilization and weaker demand from energy, chemical, and industrial customers weigh on volumes and pricing. An interesting takeaway is that, despite these cyclical headwinds and lower earnings expectations, some institutional investors still view Kirby’s constrained industry capacity as a longer-term advantage. We’ll now examine how softer inland barge...

Wondering if NVIDIA is still worth buying after its monster run, or if the real upside is already priced in? You are in the right place. The stock has pulled back about 6.6% over the last month despite being up 3.1% in the past week. It is still sitting on huge gains of 31.9% year to date and 28.1% over the last year, after a staggering 974.0% 3 year and 1305.7% 5 year climb. Recent headlines have centered on NVIDIA's dominant position in AI data center chips and expanding partnerships with...

Immatics N.V. recently announced a follow-on equity offering, issuing 12,500,000 ordinary shares at US$10.00 each to raise about US$125,000,000 in gross proceeds, with the deal expected to close on December 8, 2025, subject to customary conditions. The involvement of Jefferies, Leerink Partners, and Cantor as joint book-running managers highlights the scale of the financing and the company’s access to capital markets. We’ll now examine how this sizeable capital raise, and the associated...

In recent days, Acadia Healthcare cut its 2025 earnings guidance after a third‑party review identified sharply higher patient‑related litigation and insurance costs, prompting a sizable increase in professional and general liability reserves. The company also flagged Medicaid volume and bad debt challenges alongside the abrupt resignation of its COO, adding operational and leadership uncertainty to its legal and financial pressures. Next, we’ll examine how these sharply higher litigation...

CBL & Associates Properties (CBL) just picked up a fresh Buy rating, along with a new 25 million dollar share repurchase plan, a combination that puts management confidence and investor interest under the spotlight. See our latest analysis for CBL & Associates Properties. The upbeat Buy rating and new repurchase plan arrive as momentum is already improving. A 1 month share price return of 16.23 percent and a 1 year total shareholder return of 23.86 percent suggest sentiment is steadily...

Fresh research coverage has put Kaiser Aluminum (KALU) in the spotlight after Zacks tagged it as a Strong Buy, highlighting its value metrics and earnings expectations compared with peers. See our latest analysis for Kaiser Aluminum. That optimism has been showing up in the trading tape too, with Kaiser Aluminum’s share price at $104.62 and a 90 day share price return of 35.13 percent feeding into a 48.88 percent year to date rise. Its 1 year total shareholder return of 35.27 percent suggests...

Cabot recently reported that its Q4 fiscal 2025 earnings and sales declined from a year earlier and fell short of analyst estimates, reflecting softer demand conditions. The company also signaled that fiscal 2026 may remain challenging for its Reinforcement Materials business, even as it expects profit growth in Performance Chemicals led by Battery Materials and other growth areas. We’ll now examine how weaker Reinforcement Materials trends but improving Performance Chemicals prospects shape...

Shoals Technologies Group (SHLS) has quietly outpaced much of the clean energy space this year, with the stock up roughly 33% year to date and around 77% over the past year. See our latest analysis for Shoals Technologies Group. At a share price of $8.03, Shoals has given investors a solid boost, with a roughly 33% year to date share price return and a 77% total shareholder return over the past year. This suggests momentum is still very much on its side. If Shoals has caught your eye, this...

Wondering if PDD Holdings is still a bargain or if the easy money has already been made? You are not alone. This stock has quietly become one of the most hotly debated value stories in Chinese tech. Despite some sharp swings lately, including a 1.3% gain over the last week, a 13.7% pullback over the last month, and a still solid 21.4% gain year to date, long term holders are sitting on a 31.1% 3 year return and 17.7% over the last year. Those moves have played out against a backdrop of...

Microvast Holdings (MVST) is back on investors’ radar after fresh commentary highlighted growing commercial traction for its battery technology, including deployments with industrial partners like Škoda that underscore rising market validation. See our latest analysis for Microvast Holdings. That traction is starting to show up in the numbers, too, with the share price at $3.75 and a powerful 90 day share price return of 46.48 percent feeding into a 1 year total shareholder return above 200...

Textron (TXT) has quietly outperformed the broader market this year, and that steady climb has investors asking a simple question: does the current share price still leave meaningful upside on the table? See our latest analysis for Textron. With the share price now at $83.47 and a solid year to date share price return of just over 10 percent, Textron’s gains look more like a steady rerating as investors warm to its improving growth profile rather than a speculative spike. Multi year total...

Mohawk Industries (MHK) has been on a choppy ride lately, with the stock slipping over the week but roughly flat for the month. That mix sets up an interesting value versus momentum debate. See our latest analysis for Mohawk Industries. Over the past year, Mohawk Industries has seen its share price return slide, reflected in a recent 7 day share price return of negative 4.5 percent and a 1 year total shareholder return of negative 15.5 percent, signaling that momentum is still fading despite...

Wondering if Agilysys at around $126 a share is a hidden opportunity or just fully priced in already? You are not alone, as this stock has been quietly attracting valuation minded investors. Over the very short term it has been a bit choppy, up 2.5% in the last week but roughly flat over 30 days, while still sitting on a 106.9% gain over 3 years and 217.7% over 5 years, even though it is down 2.8% year to date and 5.7% over the last year. Recent attention has centered on Agilysys as a niche...

In early December 2025, HITRUST and Rapid7 announced a partnership integrating Rapid7’s Surface Command platform with the HITRUST assurance framework to automate continuous compliance and strengthen cyber resilience for customers. A particularly important angle is how this integration could shift customers away from manual, point-in-time audits toward ongoing, evidence-based validation that also supports lower cyber insurance costs. We’ll now explore how this move toward continuous,...